Study Summary
This trial is testing a new way to get people to be more active, called MAP to Health. They will be testing how well it works and if it is related to changes in behavior that make people more likely to be active.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 2 Secondary · Reporting Duration: 12 weeks
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Intervention development and testing
1 of 1
Experimental Treatment
47 Total Participants · 1 Treatment Group
Primary Treatment: MAP to Health · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 40 - 64 · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this clinical research currently recruiting participants?
"This research study, which was initially listed on the 17th of May 2022, is actively searching for participants. Data hosted on clinicaltrials.gov confirms this and it was last amended on August 11th of the same year." - Anonymous Online Contributor
To what extent has enrollment been maximized for this clinical investigation?
"Confirmed. According to information published on clinicaltrials.gov, the medical trial that was first announced on May 17th 2022 is presently accruing participants. 47 individuals are needed at a single location for this research project." - Anonymous Online Contributor
Who qualifies to participate in this clinical experiment?
"This research initiative requires 47 volunteers, aged 40-64 and presently engaging in little physical activity. Additional criteria include: midlife age range, willingness to increase exercise within a month of enrollment, access to a phone that can receive texts, literacy in the English language and participating in less than 10 minutes or more than 90 minutes/week of physical activity." - Anonymous Online Contributor
Are those who are 20 years or older eligible for this experiment?
"This initiative is seeking candidates aged between 40 and 64." - Anonymous Online Contributor